The zebrafish embryo as a model for assessing off-target drug effects

DMM Disease Models and Mechanisms

Volumn 3, Issue 11-12, 2010, Pages 689-692

  Strähle, Uwe ^a   Grabher, Clemens ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GALANTAMINE; PHYSOSTIGMINE; PIFITHRIN ALPHA; PROTEIN P73;

ALZHEIMER DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SCREENING; DRUG TARGETING; EMBRYO; EXPERIMENTAL MODEL; HIGH THROUGHPUT SCREENING; LOSS OF FUNCTION MUTATION; MYASTHENIA GRAVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ZEBRA FISH;

ANIMALS; BENZOTHIAZOLES; CHOLINESTERASE INHIBITORS; DNA-BINDING PROTEINS; EMBRYO, NONMAMMALIAN; HUMANS; MODELS, ANIMAL; NUCLEAR PROTEINS; PHARMACEUTICAL PREPARATIONS; PYRAZOLES; PYRIMIDINES; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; ZEBRAFISH;

ANIMALIA; DANIO RERIO; VERTEBRATA;

EID: 78649268667     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.006312     Document Type: Review

References (40)

1. Amatruda, J. F. and Patton, E. E. (2008). Genetic models of cancer in zebrafish. Int. Rev. Cell Mol. Biol. 271, 1-34.
2. Amsterdam, A., Burgess, S., Golling, G., Chen, W., Sun, Z., Townsend, K., Farrington, S., Haldi, M. and Hopkins, N. (1999). A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 13, 2713-2724.
3. Arslanova, D., Yang, T., Xu, X., Wong, S. T., Augelli- Szafran, C. E. and Xia, W. (2010). Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol. 10, 24.
4. Barros, T. P., Alderton, W. K., Reynolds, H. M., Roach, A. G. and Berghmans, S. (2008). Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br. J. Pharmacol. 154, 1400-1413.
5. Behra, M., Cousin, X., Bertrand, C., Vonesch, J. L., Biellmann, D., Chatonnet, A. and Strahle, U. (2002). Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat. Neurosci. 5, 111-118.
6. Behra, M., Etard, C., Cousin, X. and Strahle, U. (2004). The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors. Toxicol. Sci. 77, 325-333.
7. Bowman, T. V. and Zon, L. I. (2010). Swimming into the future of drug discovery: in vivo chemical screens in zebrafish. ACS Chem. Biol. 5, 159-161.
8. Buckley, C. E., Marguerie, A., Roach, A. G., Goldsmith, P., Fleming, A., Alderton, W. K. and Franklin, R. J. (2010). Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology 59, 149-159.
9. Burns, C. G., Milan, D. J., Grande, E. J., Rottbauer, W., MacRae, C. A. and Fishman, M. C. (2005). High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat. Chem. Biol. 1, 263-264.
10. Camm, A. J., Janse, M. J., Roden, D. M., Rosen, M. R., Cinca, J. and Cobbe, S. M. (2000). Congenital and acquired long QT syndrome. Eur. Heart J. 21, 1232-1237.
11. Dahme, T., Katus, H. A. and Rottbauer, W. (2009). Fishing for the genetic basis of cardiovascular disease. Dis. Model. Mech. 2, 18-22.
12. Davidson, W., Ren, Q., Kari, G., Kashi, O., Dicker, A. P. and Rodeck, U. (2008). Inhibition of p73 function by Pifithrin-alpha as revealed by studies in zebrafish embryos. Cell Cycle 7, 1224-1230.
13. Durand, E. M. and Zon, L. I. (2010). Newly emerging roles for prostaglandin E2 regulation of hematopoiesis and hematopoietic stem cell engraftment. Curr. Opin. Hematol. 17, 308-312.
14. Grabher, C. and Wittbrodt, J. (2008). Recent advances in meganuclease-and transposon-mediated transgenesis of medaka and zebrafish. Methods Mol. Biol. 461, 521-539.
15. Haffter, P., Granato, M., Brand, M., Mullins, M. C., Hammerschmidt, M., Kane, D. A., Odenthal, J., van Eeden, F. J., Jiang, Y. J., Heisenberg, C. P. et al. (1996). The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36. (Pubitemid 27056733)
16. Hao, J., Ho, J. N., Lewis, J. A., Karim, K. A., Daniels, R. N., Gentry, P. R., Hopkins, C. R., Lindsley, C. W. and Hong, C. C. (2010). In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 5, 245-253.
17. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. (1991). p53 mutations in human cancers. Science 253, 49-53.
18. Ishizaki, H., Spitzer, M., Wildenhain, J., Anastasaki, C., Zeng, Z., Dolma, S., Shaw, M., Madsen, E., Gitlin, J., Marais, R. et al. (2010). Combined zebrafish-yeast chemical-genetic screens reveal gene - copper-nutrition interactions that modulate melanocyte pigmentation. Dis. Model. Mech. 3, 639-651.
19. Kawai, H., Carlson, B. J., Okita, D. K. and Raftery, M. A. (1999). Eserine and other tertiary amine interactions with Torpedo acetylcholine receptor postsynaptic membrane vesicles. Biochemistry 38, 134-141.
20. Kawakami, K. (2005). Transposon tools and methods in zebrafish. Dev. Dyn. 234, 244-254.
21. Keating, M. T. and Sanguinetti, M. C. (2001). Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104, 569-580.
22. Kokel, D., Bryan, J., Laggner, C., White, R., Cheung, C. Y., Mateus, R., Healey, D., Kim, S., Werdich, A. A., Haggarty, S. J. et al. (2010). Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 6, 231-237.
23. Loynes, C. A., Martin, J. S., Robertson, A., Trushell, D. M., Ingham, P. W., Whyte, M. K. and Renshaw, S. A. (2009). Pivotal advance: pharmacological manipulation of inflammation resolution during spontaneously resolving tissue neutrophilia in the zebrafish. J. Leukoc. Biol. 87, 203-212.
24. Martin, J. S. and Renshaw, S. A. (2009). Using in vivo zebrafish models to understand the biochemical basis of neutrophilic respiratory disease. Biochem. Soc. Trans. 37, 830-837.
25. Mathew, L. K., Sengupta, S., Kawakami, A., Andreasen, E. A., Lohr, C. V., Loynes, C. A., Renshaw, S. A., Peterson, R. T. and Tanguay, R. L. (2007). Unraveling tissue regeneration pathways using chemical genetics. J. Biol. Chem. 282, 35202-35210.
26. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T. and MacRae, C. A. (2003). Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358.
27. Molina, G., Vogt, A., Bakan, A., Dai, W., Queiroz de Oliveira, P., Znosko, W., Smithgall, T. E., Bahar, I., Lazo, J. S., Day, B. W. et al. (2009). Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat. Chem. Biol. 5, 680-687.
28. Nasevicius, A. and Ekker, S. C. (2000). Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26, 216-220.
29. North, T., Goessling, W., Walkley, C., Lengerke, C., Kopani, K., Lord, A., Weber, G., Bowman, T., Jang, I., Grosser, T. et al. (2007). Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007-1011.
30. Payne, E. and Look, T. (2009). Zebrafish modelling of leukaemias. Br. J. Haematol. 146, 247-256.
31. Peterson, R. T., Shaw, S. Y., Peterson, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A. and Fishman, M. C. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22, 595-599.
32. Rihel, J., Prober, D. A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S. J., Kokel, D., Rubin, L. L., Peterson, R. T. et al. (2010). Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351.
33. Sullivan, C. and Kim, C. H. (2008). Zebrafish as a model for infectious disease and immune function. Fish Shellfish Immunol. 25, 341-350.
34. Weinstein, B. M., Schier, A. F., Abdelilah, S., Malicki, J., Solnica-Krezel, L., Stemple, D. L., Stainier, D. Y., Zwartkruis, F., Driever, W. and Fishman, M. C. (1996). Hematopoietic mutations in the zebrafish. Development 123, 303-309.
35. Wienholds, E., van Eeden, F., Kosters, M., Mudde, J., Plasterk, R. H. and Cuppen, E. (2003). Efficient target-selected mutagenesis in zebrafish. Genome Res. 13, 2700-2707.
36. Yang, L., Ho, N. Y., Alshut, R., Legradi, J., Weiss, C., Reischl, M., Mikut, R., Liebel, U., Muller, F. and Strahle, U. (2009). Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod. Toxicol. 28, 245-253.
37. Yeh, J. R., Munson, K. M., Elagib, K. E., Goldfarb, A. N., Sweetser, D. A. and Peterson, R. T. (2009). Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat. Chem Biol. 5, 236-243.
38. Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D. and Peterson, R. T. (2008a). Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 33-41.
39. Yu, P. B., Deng, D. Y., Lai, C. S., Hong, C. C., Cuny, G. D., Bouxsein, M. L., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C. et al. (2008b). BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat. Med. 14, 1363-1369.
40. Zon, L. I. and Peterson, R. T. (2005). In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4, 35-44.